Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres

BACKGROUND: Previous studies with bipolar androgen therapy (BAT) have shown clinical activity in metastatic Castration Resistant Prostate Cancer (mCRPC) as well as the potential to re-sensitise prostate cancer cells to prior androgen receptor-targeted agents. None of these studies had tested BAT aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarbá, Martín, Angel, Martin, Losco, Federico, Zarbá, Juan José, Pupilli, Juan Carlos, Chacon, Matías Rodrigo, Sade, Juan Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934967/
https://www.ncbi.nlm.nih.gov/pubmed/36819799
http://dx.doi.org/10.3332/ecancer.2022.1480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934967/
https://www.ncbi.nlm.nih.gov/pubmed/36819799
http://dx.doi.org/10.3332/ecancer.2022.1480

Ejemplares similares